Karyopharm Therapeutics: 3Q Earnings Snapshot
NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Monday reported a loss of $41.4 million in its third quarter.
On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 67 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.
The pharmaceutical company posted revenue of $13.1 million in the period, also beating Street forecasts. Six analysts surveyed by Zacks expected $1.6 million.
Karyopharm Therapeutics shares have risen 34% since the beginning of the year. The stock has risen 12% in the last 12 months.